Farmington, Connecticut-based Evariant has raised $42.3 million, according to an SEC filing, bringing its total funding to date to at least $68.3 million. The company’s existing investors include Lightspeed Venture Partners, Dignity Health, Salesforce, and Health Enterprise Partners.
Evariant’s solution enables healthcare providers to analyze the data they collect, execute marketing campaigns, and improve patient engagement. Built on Salseforce’s CRM platform, Evariant collects data from billing records, clinical encounters, patient’s records, and other sources to identify patients who are most likely to respond to specific marketing campaigns.
Providers on their end can use this data along with other information to plan their marketing campaigns, communicate with other members on their team, access marketing reports, and reach out to patients. Also, they can manage physicians in their network by tracking their referral activity and use that data to understand physician volume and loyalty.
Evariant’s customers include University of Chicago Medicine, Scripps Health, and Orlando Health.